Reviewing Virpax Pharmaceuticals (NASDAQ:VRPX) and Zomedica (OTCMKTS:ZOMDF)
Financial Comparison: Virpax Pharmaceuticals (NASDAQ:VRPX) versus Merck KGaA (OTCMKTS:MKGAF)
Nabriva Therapeutics (NASDAQ:NBRV) versus Virpax Pharmaceuticals (NASDAQ:VRPX) Head-To-Head Contrast
Virpax Pharmaceuticals Announces Reverse Stock Split
Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND
Virpax Looking to Use MET to Develop Intranasal COVID Vaccine
Virpax's NES100 to be Presented at The Society of Toxicology by NCATS
Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate
Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference
Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals' $6 Million Follow-On Offering
Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
This FactSet Research Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday
Crude Oil Gains Over 1%; Virpax Pharmaceuticals Shares Spike Higher
Why Is Virpax Pharmaceuticals (VRPX) Stock Up 98% Today?
Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?
Spotting Penny Stocks With Breakout Potential, 3 Tips
What's Going With Penny Stock Virpax Pharmaceuticals On Monday?
Why Is Virpax Pharmaceuticals (VRPX) Stock Up 97% Today?
Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
Why Is Virpax Pharmaceuticals (VRPX) Stock Down 61% Today?
Virpax Announces Pricing of $2.25 Million Public Offering
Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments
Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
Virpax Pharmaceuticals Reports 2023 Year-End Results
Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price
Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research
Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting
Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
Virpax Pharmaceuticals Announces Leadership Transition
Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research
Virpax Pharmaceuticals Announces Results of Probudur™ Dose Escalation Studies
Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses
Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals
Virpax® Pharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference
Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments
Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method
Virpax Pharma Expands AnQlar Worldwide Licensing Pact In COVID-19
Virpax® Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference
Virpax Pharmaceuticals Stock (VRPX): Why The Price Increased Today
4 Reddit Penny Stocks To Buy For Under $5 As Trump Stocks Jump
Best Penny Stocks To Buy Today? Retail Traders Are Watching These Now
Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock
Virpax® Pharmaceuticals Announces Pricing of $40 Million Public Offering of Common Stock
Virpax: Targeting Pain At Its Source